First group 1 mGluR antagonist with submicromolar potency described by Lilly Sep. 17, 1998 No Comments
Inflammatory/immunological disease collaboration initiated by BMS and Molecumetics Sep. 15, 1998 No Comments
Tularik/JT establish new collaboration to develop orphan nuclear receptor modulators Sep. 10, 1998 No Comments